Loss of heterozygosity analysis of microsatellites on multiple chromosome regions in dysplasia and squamous cell carcinoma of the esophagus

Experimental and Therapeutic Medicine

Volumn 2, Issue 5, 2011, Pages 997-1001

  Liu, Ming ^a   Zhang, Feng ^b   Liu, Shen ^a   Zhao, Wen ^a   Zhu, Jing ^a   Zhang, Xiaoli ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Esophageal squamous cell carcinoma; Loss of heterozygosity; Microsatellite

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CHINA; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME 9Q; CLINICAL ARTICLE; DETERIORATION; DYSPLASIA; EARLY DIAGNOSIS; ESOPHAGUS CARCINOMA; ESOPHAGUS DYSPLASIA; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRECANCER; SQUAMOUS CELL CARCINOMA;

EID: 79960285271     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.297     Document Type: Article

References (18)

1. Dawsey SM, Lewin KJ, Liu FS, Wang GQ and Shen Q: Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer 73: 2027-2037, 1994.
2. Zhang XL, Fu WL, Zhao HX, Zhou LX, Huang JF and Wang JH: Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients. Clin Chim Acta 358: 75-80, 2005.
3. Maley CC, Galipeau PC, Li X, et al: The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 64: 7629-7633, 2004.
4. Maitra A, Wistuba II, Washington C, et al: High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 159: 119-130, 2001.
5. Wang Z and Lai FM: [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia]. Zhonghua Nan Ke Xue 10: 26-28; 31, 2004.
6. Karakosta A, Golias C, Charalabopoulos A, Peschos D, Batistatou A and Charalabopoulos K: Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. J Exp Clin Cancer Res 24: 505-514, 2005.
7. Ha PK, Pilkington TA, Westra WH, Sciubba J, Sidransky D and Califano JA: Progression of microsatellite instability from premalignant lesions to tumors of the head and neck. Int J Cancer 102: 615-617, 2002.
8. Dawsey SM, Lewin KJ, Wang GQ, et al: Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 74: 1686-1692, 1994.
9. Shen D, Nooraie F, Elshimali Y, et al: Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 37: 1583-1591, 2006.
10. Zhou G, Li H, DeCamp D, et al: 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 1: 117-124, 2002.
11. Yang L, Leung AC, Ko JM, et al: Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. Oncogene 24: 697-705, 2005.
12. Huang XP, Wei F, Liu XY, et al: Allelic loss on 13q in esophageal squamous cell carcinomas from northern China. Cancer Lett 185: 87-94, 2002.
13. Hu N, Huang J, Emmert-Buck MR, et al: Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 7: 883-891, 2001.
14. Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW and Dinjens WN: The molecular biology of esophageal adenocarcinoma. J Surg Oncol 92: 169-190, 2005.
15. Partridge M, Pateromichelakis S, Phillips E, Emilion G and Langdon J: Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res 7: 1860-1866, 2001.
16. Cheng L, Bostwick DG, Li G, et al: Allelic imbalance in the clonal evolution of prostate carcinoma. Cancer 85: 2017-2022, 1999.
17. Heim S, Teixeira MR, Dietrich CU and Pandis N: Cytogenetic polyclonality in tumors of the breast. Cancer Genet Cytogenet 95: 16-19, 1997.
18. He S, Guo GM, Liu FX, et al: Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 134: 307-315, 2008.